Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation (Q44945294)

7 December 2017

Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation (English)

1 reference

7 December 2017

0 references

0 references

S S Ghosh

1

1 reference

7 December 2017

H D Massey

2

1 reference

7 December 2017

R Krieg

3

1 reference

7 December 2017

Z A Fazelbhoy

4

1 reference

7 December 2017

S Ghosh

5

1 reference

7 December 2017

D A Sica

6

1 reference

7 December 2017

I Fakhry

7

1 reference

7 December 2017

T W B Gehr

8

1 reference

7 December 2017

18 February 2009

1 reference

American Journal of Physiology - Renal Physiology

7 December 2017

1 reference

7 December 2017

296

1 reference

7 December 2017

F1146-57

1 reference

7 December 2017

5

1 reference

How does proteinuria cause progressive renal damage?

7 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Selective activation of PPARgamma in breast, colon, and lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Curcumin and cancer: an "old-age" disease with an "age-old" solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Peroxisome Proliferator-Activated Receptor γ Agonist Provides Superior Renal Protection versus Angiotensin-Converting Enzyme Inhibition in a Rat Model of Type 2 Diabetes with Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Curcumin protects against ischemia/reperfusion injury in rat kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Metabolic actions of angiotensin receptor antagonists: PPAR-gamma agonist actions or a class effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Curcumin blocks fibrosis in anti-Thy 1 glomerulonephritis through up-regulation of heme oxygenase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

The role of the renin-angiotensin system in cholesterol and puromycin mediated renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Cardiac hypertrophy in neonatal nephrectomized rats: the role of the sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Introduction to NF-kappaB: players, pathways, perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Anti-inflammatory effect of hepatocyte growth factor in chronic kidney disease: targeting the inflamed vascular endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Transcription factor-kappa B (NF-kappa B) and renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Curcumin: from ancient medicine to current clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Clinical studies with curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5'-flanking region

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Attenuation of renal fibrosis by curcumin in rat obstructive nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Nuclear factor-kappaB as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Direct evidence of nitric oxide presence within mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Macrophage diversity in renal injury and repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Protection of the kidney by thiazolidinediones: an assessment from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Pharmacokinetics and pharmacodynamics of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Glucuronidase deconjugation in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Tumor necrosis factor-alpha inhibits peroxisome proliferator-activated receptor gamma activity at a posttranslational level in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Regulation of PPARgamma function by TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Macrophage-specific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90732.2008

Curcumin prevents and reverses murine cardiac hypertrophy

21 January 2018

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1172/JCI32865

Identifiers

DOI

10.1152/AJPRENAL.90732.2008

1 reference

7 December 2017

1 reference